Campath-1H Induction to Allow Steroid Free Immunosuppression in Pediatric Renal Transplantation
Sponsor: University of Wisconsin, Madison
Terminated
Enrollment suspended pending protocol revision to change study to observational
Other terminated trials from University of Wisconsin, Madison
This PHASE1/PHASE2 trial investigates Disorder Related to Renal Transplantation and is currently terminated or withdrawn. University of Wisconsin, Madison leads this study, which shows 9 recorded versions since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Terminated PHASE1_PHASE2
▶ Show 4 earlier versions
-
Oct 2020 — Jan 2021 [monthly]
Terminated PHASE1_PHASE2
-
Jun 2018 — Oct 2020 [monthly]
Terminated PHASE1_PHASE2
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE1_PHASE2
First recorded
Jun 2004
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Wisconsin, Madison
For direct contact, visit the study record on ClinicalTrials.gov .